Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends.

By Ruth Etzioni, D. Penson, J. Legler, Dante di Tommaso, R. Boer, P. Gann, E. Feuer. Journal of the National Cancer Institute, 2002

863 citations recorded by the source corpus.

Subfields: Epidemiology, Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/4cf990ca1d66e4a94c125534526084a4f24da232

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

1. A. Jemal
2. Elizabeth E. Ward
3. R. Siegel

In Pulmonary and Respiratory Medicine

1. A. Jemal
2. Elizabeth E. Ward

Citations in the corpus

• Epidemiology of Prostate Cancer (2019, neutral): “According to recently conducted research studies, around 20-40% of the prostate cancer cases in the USA and Europe could be due to overdiagnosis through extensive PSA testing [12, 15, 16].”
• Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer. (2003, methodology): “95, No. 12, June 18, 2003 ARTICLES 875 Our results on overdetection should be compared with the results of Zappa et al. (21) and Etzioni et al. ( 22 ), who used the same definition of overdetection that we did, i.e., the detection of cancer that would not have been found in the absence of screening.”
• Annual report to the nation on the status of cancer, 1975–2001, with a special feature regarding survival (2004, background): “However, because a high proportion of men are found to have clinically occult cancer at autopsy,(38,39) it is assumed that some prostate cancers identified by PSA would not have otherwise presented as clinical disease.(40) The extent to which overdiagnosis, length-time, and leadtime biases have cont”
• A Unique Metastasis Gene Signature Enables Prediction of Tumor Relapse in Early Stage Hepatocellular Carcinoma Patients (2010, neutral): “If a tumor is detected and treated before it spreads, the chances of long-term survival should be increased (34).”
• Gut Feelings: The Intelligence of the Unconscious (2007, neutral): “Etzioni et al., 2002.”
• The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. (2005, background): “The best known example for overdiagnosis due to increased screening is prostate cancer ( 7 ).”